
Lipid Nanoparticles Formulated with a Novel Cholesterol-Tailed Ionizable Lipid Markedly Increase mRNA Delivery Both in ...
Introduction The rise of nucleic acid therapeutics, particularly messenger RNA (mRNA) based treatments delivered via lipid nanoparticles (LNPs), has been monumental and largely catalyzed by the global response to the COVID-19 pandemic.1–3 mRNA and other …